I'm an avid investor with a long-term, and sometimes contrarian, approach to equities investing. I started out as a Tech analyst but now also cover Commodities and Energy sectors as the world navigates the energy transition.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (o ...

分析师背景 - 专注于科技行业股票研究 包括半导体 人工智能和云软件等关键领域[1] - 研究范围延伸至医疗技术 国防技术和可再生能源等其他领域[1] - 曾在硅谷领导团队 任职于苹果和谷歌等全球大型科技公司[1] 持仓披露 - 通过股票所有权 期权或其他衍生品对PANW持有长期多头头寸[2] 内容免责声明 - 文章内容仅代表作者个人观点 未获得除Seeking Alpha外的任何补偿[2] - 与提及股票公司无任何业务关系[2] - 分析师包含专业投资者和个体投资者 可能未经机构或监管机构许可认证[3]

Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .The major indexes continue to grind up despite increasing signs of trouble in the jobs and housing markets. Despite this, headline economic growth appears strong. Q2 GDP just got revised up again this weekBret leads the investing group ...

This is a macro article, meant to show just how difficult it is to find quality, valuation, and technical price support in this market. That has been my most consistent argument about my own conservative equity positioning all year.I'm Rob Isbitts, founder of Sungarden Investment Publishing. I run the new investing group Sungarden Investors Club, a community dedicated to navigating the modern investment climate with humility, discipline, and a non-traditional approach to income investing. I've been charting ...

Covered-call funds have evolved both rapidly and significantly in the last 5 years. While the original options-based investments, such as the Global X Funds, focused on simple buy and write strategies mostly involvingAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other th ...

My attempts at trying to capture Tesla's fundamentals through its price action have not been particularly accurate. After sitting on the fence for a while, I found Tesla ripe for a sell in July 2025. WhatI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I led teams in model va ...

In the fourth quarter last year, Gogo Inc. (NASDAQ: GOGO ) completed its acquisition of Satcom Direct (SD) for the total value of $415 million in fixed payment, $375 million in cash, and $40 million in GOGO stock (the companyI'm a self taught equity analyst, I run a consultation firm in South Africa where we help clients with estimating the value of construction projects, over the past 5 years I've been retail investing and learning more about how the stock market works, following the work of Ben Graham and ...

Robinhood Markets has proven to be one of the trickier companies to evaluate. The company is enjoying exceptional growth, societal tailwinds could drive more business the company’s way, and it’s one of the hottest brands in the finance space. That said, the sky-high valuation isMarkets rise and fall, booms come and go, and the world keeps ticking. Ultimately, I believe observing megatrends, as difficult as they can be to spot, let alone fully comprehend, can yield insights into the advance of human society, ...

Equity Research Analyst with a broad career in the financial market, covered both Brazilian and global stocks. As a value investor, my analysis is primarily fundamental, focusing on identifying undervalued stocks with growth potential. Feel free to reach out for collaborations or to connect!Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it ...

I’m an equity analyst and founder of Goulart’s Restaurant Stocks, a research firm focused on the U.S. restaurant industry — from quick-service and fast casual to fine dining and niche concepts. I lead all thematic research and valuation efforts, applying advanced financial modeling, sector-specific KPIs, and strategic insights to uncover hidden value across public equities. In addition to restaurants, I cover consumer discretionary, food & beverage, casinos & gaming, and IPOs, with a particular focus on mic ...